Joel D A Tyndall

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 13

Top Venues

Journal of fungi (Basel, Switzerland)

Journal of medicinal chemistry

Medicinal research reviews

RSC medicinal chemistry

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Queensland

Australia

PHD :: Centre for Drug Design and Development

Publications

Jimin Hwang, Sonya Mros, Allan B Gamble, Joel D A Tyndall, Arlene McDowell
Improving Antibacterial Activity of a HtrA Protease Inhibitor JO146 against Helicobacter pylori : A Novel Approach Using Microfluidics-Engineered PLGA Nanoparticles. Pharmaceutics 14 (2) (2022)
Joel D A Tyndall
S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2. Journal of medicinal chemistry 65 (9) (2022)
Kiel Hards, Chen-Yi Cheung, Natalie Waller, Cara Adolph, Laura Keighley, Zhi Shean Tee, Liam K Harold, Ayana Menorca, Richard S Bujaroski, Benjamin J Buckley, Joel D A Tyndall, Matthew B McNeil, Kyu Y Rhee, Helen K Opel-Reading, Kurt L Krause, Laura Preiss, Julian D Langer, Thomas Meier, Erik J Hasenoehrl, Michael Berney, Michael J Kelso, Gregory M Cook
An amiloride derivative is active against the F 1 F o -ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis. Communications biology 5 (1) (2022)
Aggie Lawer, Chelsea Tyler, Kiel Hards, Laura M Keighley, Chen-Yi Cheung, Fabian Kierek, Simon Su, Siddharth S Matikonda, Tyler McInnes, Joel D A Tyndall, Kurt L Krause, Gregory M Cook, Allan B Gamble
Synthesis and Biological Evaluation of Aurachin D Analogues as Inhibitors of Mycobacterium tuberculosis Cytochrome bd Oxidase. ACS medicinal chemistry letters 13 (10) (2022)
Yasmeen N Ruma, Mikhail V Keniya, Joel D A Tyndall, Brian C Monk
Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host. Journal of fungi (Basel, Switzerland) 8 (1) (2022)
Ian Liddle, Michelle Glass, Joel D A Tyndall, Andrea J Vernall
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges. RSC medicinal chemistry 13 (5) (2022)
Danyon O Graham, Rajni K Wilson, Yasmeen N Ruma, Mikhail V Keniya, Joel D A Tyndall, Brian C Monk
Structural Insights into the Azole Resistance of the Candida albicans Darlington Strain Using Saccharomyces cerevisiae Lanosterol 14α-Demethylase as a Surrogate. Journal of fungi (Basel, Switzerland) 7 (11) (2021)
Phuc N H Trinh, Daniel J W Chong, Katie Leach, Stephen J Hill, Joel D A Tyndall, Lauren T May, Andrea J Vernall, Karen J Gregory
Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors. Journal of medicinal chemistry 64 (12) (2021)
Zohaib Rana, Joel D A Tyndall, Muhammad Hanif, Christian G Hartinger, Rhonda J Rosengren
Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Sameek Singh, Samantha L Cooper, Jacqueline R Glenn, Jessica Beresford, Lydia R Percival, Joel D A Tyndall, Stephen J Hill, Laura E Kilpatrick, Andrea J Vernall
Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools. RSC advances 8 (29) (2018)
Anna G Cooper, Caitlin R M Oyagawa, Jamie J Manning, Sameek Singh, Sarah Hook, Natasha L Grimsey, Michelle Glass, Joel D A Tyndall, Andrea J Vernall
Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold. MedChemComm 9 (12) (2018)
Ayodeji A Agbowuro, Wilhelmina M Huston, Allan B Gamble, Joel D A Tyndall
Proteases and protease inhibitors in infectious diseases. Medicinal research reviews 38 (4) (2017)
Joel D A Tyndall, Manya Sabherwal, Alia A Sagatova, Mikhail V Keniya, Jacopo Negroni, Rajni K Wilson, Matthew A Woods, Klaus Tietjen, Brian C Monk
Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals. PloS one 11 (12) (2016)

Joel D A Tyndall.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joel D A Tyndall